Pharmafile Logo
Pharmafocus logo
Advanced Search

J&J

Showing 9 posts of 219 posts found.

Pepscan and Tibotec sign peptides deal

September 15, 2010
Research and Development, Sales and Marketing CLIPS, HIV, J&J, JJ, Pepscan, Tibotec

Pepscan Therapeutics, the biotech firm focusing on protein mimicry technology has signed a deal with Tibotec. Netherlands-based Pepscan will use …

News

J&J chalks up ninth product recall in 2010

August 26, 2010
Manufacturing and Production J&J, JJ

 Johnson & Johnson has recalled around 100,000 boxes of its disposable contact lens because of a manufacturing defect, bringing the …

News

J&J appoints quality tsar to oversee manufacturing revamp

August 24, 2010
Manufacturing and Production J&J, JJ, recalls

 Johnson & Johnson plans to beef up senior management across its three business units as part of a broader programme …

News

J&J post modest second quarter increase

July 21, 2010
Sales and Marketing 2010 financials, J&J, JJ, Q2

Johnson & Johnson has seen a modest increase in sales for the second quarter, buoyed primarily by international sales and …

News

J&J cited by FDA for another manufacturing facility

July 20, 2010
Manufacturing and Production J&J, JJ, manufacturing compliance

Another week, another raft of bad news for Johnson & Johnson’s manufacturing division. With one production facility already shut down …

News

J&J faces FDA scrutiny for another manufacturing unit

May 27, 2010
Manufacturing and Production Advanced Sterilization Products, Ethicon, J&J, JJ, McNeil, manufacturing compliance

Another Johnson & Johnson subsidiary has come under scrutiny by FDA for failing to meet quality standards in its manufacturing. …

News

Pharma mergers and acquisitions in 2009

December 22, 2009
Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review

This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …

Feature

Johnson & Johnson to buy Cougar Biotechnology

May 27, 2009
Research and Development, Sales and Marketing Cougar, J&J, JJ

Johnson & Johnson is to buy Los Angeles-based biotech firm Cougar Biotechnology for $970 million.The purchase, expected to go through …

News

Simponi approved in Canada

April 16, 2009
Research and Development, Sales and Marketing J&J, JJ, Simponi

Johnson & Johnson's monoclonal antibody Simponi has been given regulatory approval in Canada.Simponi (golimumab) has been given the green light …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023